Analysts told Decrypt though ETF approval rumors are adding to optimism, it’s MEI Pharma’s buy-in last month that is really ...

MEI Pharma announced its first LTC purchase, sparking a rally for one of the oldest and well-established crypto coins.

San Diego-based MEI Pharma (NASDAQ:MEIP) has acquired 929,548 Litecoin (CRYPTO: LTC) tokens, becoming the first U.S.-listed ...

MEI Pharma unveils a $100M Litecoin treasury initiative, gaining Litecoin Foundation support and boosting shares 50% intraday ...

MEI Pharma raises $100 million to buy Litecoin, boosting stock value and signaling confidence in LTC's future growth.

MEI Pharma, Inc. (NASDAQ: MEIP) (“MEI” or “the Company”) today announced the acquisition of 929,548 Litecoin (LTC) tokens at an average price of $107.58, successfully launching a major institutional ...

MEI Pharma launched a $100 million Litecoin treasury strategy with backing from GSR, Titan Partners, and the Litecoin Foundation. Litecoin creator Charlie Lee joined MEI’s board, marking a rare ...

Litecoin (LTC), one of the oldest and most recognized cryptocurrencies, is showing renewed strength in the market, surging with institutional interest and ...

In other recent news, MEI Pharma, Inc. has announced a significant financial strategy shift involving a $100 million private placement aimed at establishing a Litecoin treasury reserve.

MEI Pharma (MEIP) shares soared Friday premarket as it unveiled a $100 million private placement to fund its new Litecoin treasury strategy, marking a groundbreaking shift in corporate crypto ...

MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange ...